Familial partial lipodystrophy type 1. A rare or underdiagnosed syndrome?

被引:0
|
作者
Soutelo, Jimena [1 ]
Grueneisen, Mariana [1 ]
Fritz, Clara [1 ]
Sordo, Laura [1 ]
Powazniak, Yanina [2 ]
Lutfi, Ruben [1 ]
机构
[1] Complejo Med Churruca Visca, Serv Endocrinol, RA-1437 Buenos Aires, DF, Argentina
[2] Argenomics SA, Buenos Aires, DF, Argentina
关键词
familial partial lipodystrophy; Kobberling syndrome; DUNNIGAN VARIETY; MUTATION; GENE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial partial lipodystrophy ( FPL) type 1 is a syndrome characterized by loss of subcutaneous fat in arms and legs and an excess of body fat in face, neck, and torso. This rare syndrome is usually diagnosed when patients present cardiovascular complications or pancreatitis due to the severe metabolic abnormalities. Here we present the case of a 45 year old diabetic female without any pathological family history, a poor glycemic control ( HbA1c 11.7%), hypertriglideridemia ( 3000 mg/ dl), a body mass index ( BMI) of 38, thin limbs, subcutaneous fat loss in gluteal area and ledge of fat above them, prominent veins in lower extremities, moon face, and acanthosis nigricans; as well as hypertension ( 150/ 100 mmHg) and subcutaneous folds measuring less than average were observed. Hypercortisolism was discarded and leptin levels were measured ( 16.8 mg/ ml, VR: BMI > 30: 50 mg/ ml). Due to these clinical and biochemical manifestations, and low leptin levels ( 16.8 mg/ ml), Kobberling syndrome was suspected; however, LMNA mutation analysis was negative. Changes in lifestyle and treatment with fenofibrate, biphasic insulin 50/ 50, and enalapril were initiated showing a a significant metabolic improvement: HbA1c ( 7.8%) and TG ( 243 mg/ dl). FPL type 1 is a familial disease, although there are spontaneous cases. No specific mutation is responsible for this syndrome. Due to its clinical manifestations, Cushing syndrome must be discarded.
引用
收藏
页码:41 / 43
页数:3
相关论文
共 50 条
  • [21] Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2
    Lazarte, Julieta
    Wang, Jian
    McIntyre, Adam D.
    Hegele, Robert A.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2021, 15 (05) : 653 - 657
  • [22] Efficacy of pioglitazone in familial partial lipodystrophy of the Dunnigan type: a case report
    Moreau, F.
    Boullu-Sanchis, S.
    Vigouroux, C.
    Lucescu, C.
    Lascols, O.
    Sapin, R.
    Ruimy, D.
    Guerci, B.
    Pinget, M.
    Jeandidier, N.
    DIABETES & METABOLISM, 2007, 33 (05) : 385 - 389
  • [23] A new type of familial partial lipodystrophy: distinctive fat distribution and proteinuria
    Yurekli, Banu
    Kutbay, Nilufer Ozdemir
    Altay, Canan
    Unlu, Sadiye Mehtat
    Sen, Sait
    Onay, Huseyin
    Atik, Tahir
    Akinci, Baris
    ENDOCRINE RESEARCH, 2018, 43 (04) : 258 - 263
  • [24] DUNNIGAN-TYPE FAMILIAL PARTIAL LIPODYSTROPHY IN A LARGE PORTUGUESE KINDRED
    Alves, A. C.
    Moldovan, O.
    Medeiros, A. M.
    Sousa, A. B.
    Bourbon, M.
    ATHEROSCLEROSIS, 2015, 241 (01) : E116 - E116
  • [25] Dunnigan-type familial partial lipodystrophy: attention to precocious diagnosis
    Silveira Martins Leao, Lenora Maria Camarate
    de Alencar, Renata Carvalho
    Rodrigues, Gisele da Cunha
    Bouzas, Izabel
    Gallo, Paulo
    Rossini, Ana
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2011, 33 (02): : 99 - 103
  • [26] Familial partial lipodystrophy type 3: a new mutation on the PPARG gene
    Lau, Eva
    Carvalho, Davide
    Oliveira, Joana
    Fernandes, Susana
    Freitas, Paula
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 14 (02): : 317 - 320
  • [27] Cardiac phenotype in familial partial lipodystrophy
    Eldin, Abdelwahab Jalal
    Akinci, Baris
    da Rocha, Andre Monteiro
    Meral, Rasimcan
    Simsir, Ilgin Yildirim
    Adiyaman, Suleyman Cem
    Ozpelit, Ebru
    Bhave, Nicole
    Gen, Ramazan
    Yurekli, Banu
    Ozdemir Kutbay, Nilufer
    Siklar, Zeynep
    Neidert, Adam H.
    Hench, Rita
    Tayeh, Marwan K.
    Innis, Jeffrey W.
    Jalife, Jose
    Oral, Hakan
    Oral, Elif A.
    CLINICAL ENDOCRINOLOGY, 2021, 94 (06) : 1043 - 1053
  • [28] A case report of 'atypical' familial partial lipodystrophy type 2 (Dunnigan type 2)
    Cronin, T.
    Rasheed, E.
    Mac Aogain, M.
    Savage, S.
    Walsh, E.
    Pazderska, A.
    Crowley, V. E. F.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 3) : 105 - 105
  • [29] Polycystic ovary syndrome in familial partial lipodystrophy type 2 (FPLD2): basic and clinical aspects
    Gambineri, Alessandra
    Zanotti, Laura
    NUCLEUS, 2018, 9 (01) : 392 - 397
  • [30] AN UNUSUAL TYPE OF FAMILIAL LIPODYSTROPHY
    JOHANSEN, K
    RASMUSSEN, MH
    KJEMS, LL
    ASTRUP, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12): : 3442 - 3446